The surge in research and development activities focused on personalized medicine coincides with the rapidly decreasing cost of human genome mapping and a greater understanding of disease heterogeneity. As a researcher, you struggle with high attrition rates based on lack of clinical efficacy. It is crucial to your studies to utilize high-quality, well-characterized human specimens and comprehensive tissue-based research services.
Look to BioIVT for expertise in the processes required for ethical acquisition of biospecimens that cover a wide range of disease states and the protocols needed to produce reliable data. With over 425-IRB-approved clinical sites, BioIVT provides clinical specimens for nearly all disease states.
Used throughout drug discovery and development, BioIVT's ASTERAND® Elite Human Tissue Specimens provide high-quality human biospecimens and associated clinical information, collected and processed using rigorous criteria for procurement and quality control.
BioIVT has a worldwide network of hospitals working exclusively to procure high-quality biological samples for our onsite tissue bank. This dynamic network makes BioIVT unique in the biobanking industry and allows us to provide you with many hard-to-procure, treatment-naive tissue specimens in several formats.
Standard protocols are used to adhere to the highest standards of sample integrity, including difficult-to-procure treatment-naive tumor samples. Standard tissue products are generally available for next-day shipping to keep your research moving.
